Next Article in Journal
The Effect of Dietary Saccharomyces cerevisiae on Growth Performance, Oxidative Status, and Immune Response of Sea Bream (Sparus aurata)
Next Article in Special Issue
Fatty Acid Composition of Milk from Mothers with Normal Weight, Obesity, or Gestational Diabetes
Previous Article in Journal
Tea Tree Oil Nanoemulsion-Based Hydrogel Vehicle for Enhancing Topical Delivery of Neomycin
Previous Article in Special Issue
High Fat High Sucrose Diet Modifies Uterine Contractility and Cervical Resistance in Pregnant Rats: The Roles of Sex Hormones, Adipokines and Cytokines
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Life
Volume 12
Issue 7
10.3390/life12071012
life-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dietary and Antioxidant Vitamins Limit the DNA Damage Mediated by Oxidative Stress in the Mother–Newborn Binomial

by
Hector Diaz-Garcia
1,2,
Jenny Vilchis-Gil
3,4,
Pilar Garcia-Roca
5,
Miguel Klünder-Klünder
6,
Jacqueline Gomez-Lopez
7,
Javier T. Granados-Riveron
1 and
Rocio Sanchez-Urbina
1,8,*
1
Unidad de Investigación en Malformaciones Congénitas, Hospital Infantil de Mexico Federico Gómez, Mexico City 06720, Mexico
2
Sección de Estudios de Posgrado e Investigación de la Escuela Superior de Medicina del Instituto Politécnico Nacional, Mexico City 11340, Mexico
3
Unidad de Investigación Epidemiológica en Endocrinología y Nutrición, Hospital Infantil de Mexico Federico Gómez, Mexico City 06720, Mexico
4
Facultad de Medicina, Universidad Nacional Autónoma de Mexico, Mexico City 04510, Mexico
5
Unidad de Investigación y Diagnóstico en Nefrología y Metabolismo Mineral Ósea, Hospital Infantil de Mexico Federico Gómez, Mexico City 06720, Mexico
6
Subdirección de la Gestión de la Investigación, Hospital Infantil de Mexico Federico Gómez, Mexico City 06720, Mexico
7
Hospital Militar de Especialidades de la Mujer y Neonatología, Secretaria de la Defensa Nacional, Mexico City 11200, Mexico
8
Escuela Superior de Medicina del Instituto Politécnico Nacional, Mexico City 11340, Mexico
*
Author to whom correspondence should be addressed.
Life 2022, 12(7), 1012; https://doi.org/10.3390/life12071012
Submission received: 17 June 2022 / Revised: 1 July 2022 / Accepted: 3 July 2022 / Published: 8 July 2022
(This article belongs to the Special Issue Effect of Nutrition during Pregnancy on the Mother and the Newborn)
Browse Figures
Versions Notes

Abstract

During pregnancy, appropriate nutritional support is necessary for the development of the foetus. Maternal nutrition might protect the foetus from toxic agents such as free radicals due to its antioxidant content. In this study, 90 mothers and their children were recruited. DNA damage mediated by oxidative stress (OS) was determined by the levels of 8-hidroxy-2′-deoxyguanosine (8-OHdG) in the plasma of women and umbilical cord blood. The mothers and newborns were categorised into tertiles according to their 8-OHdG levels for further comparison. No relevant clinical differences were observed in each group. A strong correlation was observed in the mother–newborn binomial for 8-OHdG levels (Rho = 0.694, p < 0.001). In the binomial, a lower level of 8-OHdG was associated with higher consumption of calories, carbohydrates, lipids, and vitamin A (p < 0.05). In addition, the levels of 8-OHdG were only significantly lower in newborns from mothers with a higher consumption of vitamin A and E (p < 0.01). These findings were confirmed by a significant negative correlation between the 8-OHdG levels of newborns and the maternal consumption of vitamins A and E, but not C (Rho = −0.445 (p < 0.001), −0.281 (p = 0.007), and −0.120 (p = 0.257), respectively). Multiple regression analysis showed that the 8-OHdG levels in mothers and newborns inversely correlated with vitamin A (β = −1.26 (p = 0.016) and −2.17 (p < 0.001), respectively) and pregestational body mass index (β = −1.04 (p = 0.007) and −0.977 (p = 0.008), respectively). In conclusion, maternal consumption of vitamins A and E, but not C, might protect newborns from DNA damage mediated by OS.

1. Introduction

Quality and quantity of diet depend on the interplay between complex factors, such as the environment, personal economics, cultural background, and food availability [1]. During pregnancy, nutritional changes take place to supply the demands of both the mother and the foetus, and they are important for the normal development of the foetus [2]. Besides the mother’s diet, the foetus is susceptible to damage by maternal diseases, such as type 2 diabetes (T2D), obesity [3,4,5], or smoking [6,7], and the consumption of alcohol [8,9]. Under these conditions, free radicals (FR) are overproduced and accumulate in cells.
FR are molecules with an unpaired electron in their orbitals, which they donate to biomolecules, such as proteins, lipids, or DNA, to stabilise their own structure [10] while altering the structure and function of the biomolecule. Oxidative stress (OS) is a physiological status characterised by an accumulation of FR due to an imbalance in their production and elimination [11]. OS represents a danger to the organs and tissues of the mother and the foetus, but the antioxidant enzymatic system (superoxide dismutase, glutathione peroxidase, catalase, etc.) and the non-enzymatic system (transferrin, lactoferrin, phytochemicals, vitamins, etc.) limit FR overproduction [12,13,14,15].
OS might cause foetus damage [16] or predispose the progeny to develop certain diseases during their lifetime, such as cardiovascular diseases, T2D, or cancer [17]. Maternal diet might be a factor that influences the predisposition of the progeny toward these diseases.
Among the nitrogenous bases of DNA, guanine is the most susceptible to oxidation by OS [18]. Guanine oxidation produces 8-hydroxy-2′-deoxyguanosine (8-OHdG), which is used as a marker for OS-mediated DNA damage [19]. Increased 8-OHdG is associated with the progression or prognosis of cardiovascular diseases, T2D [20,21], cancer [22,23], and other diseases in adults [24,25,26,27,28,29]. In pregnant women, high levels of 8-OHdG have been associated with restriction of foetal growth [30,31], neural tube defects [32], and orofacial clefts [33] in the progeny. On the other hand, in mothers, high 8-OHdG levels were associated with gestational diabetes mellitus (GDM) [34,35], and more recently, it was observed in pregnant women infected by severe acute respiratory syndrome coronavirus 2 [36].
Food antioxidants such as vitamins A, C, and E have been widely studied for their ability to regulate and maintain physiological levels of OS in the body [37]. These vitamins, when used in highly pro-oxidative conditions (smokers), decreased the levels of 8-OHdG [38]. However, there is limited information about the effect of the maternal diet on OS-mediated DNA damage in mother–newborn binomials. The aim of this study was to determine whether the consumption of calories, macronutrients, and the vitamins A, C, and E during pregnancy modified OS-mediated DNA damage at the end of pregnancy in both the mother and the child. In this study, there was a strong correlation between 8-OHdG levels in the mother–child binomial, and the intake of vitamin A during pregnancy decreased 8-OHdG levels in the mothers and their children.

2. Materials and Methods

2.1. Participants

This study was performed with 90 healthy women and their children. Participants were recruited between January 2016 and December 2017. All women signed an informed consent form. The study was conducted in accordance with the latest version of the Declaration of Helsinki, and the protocol was approved by the Ethics and Biosecurity committees of the Hospital Infantil de Mexico Federico Gómez. We included women who did not have any nutritional conditions before pregnancy, delivered 38 to 40 weeks from their last menstruation, and had adequate prenatal control, including monthly medical consultations from the first trimester of pregnancy and a minimum of two normal ultrasonography results. Women who had pre-eclampsia, type 1 diabetes, T2D, or GDM were excluded. Data on the weight of the women before pregnancy were obtained from their medical history record. A physician measured the heights of the women by using a stadiometer (SECA, Hamburg, Germany) at the time of recruitment. The anthropometric data on weight and length, gestational age, mode of delivery, and sex of newborns were registered at birth. Mothers were categorised according to their pregestational body mass index (BMI, kg/m2) into normal-weight, BMI 18.5–24.9; overweight, BMI 25–29.9; and obese, BMI 30 and above. The pregestational record of smoking (number of cigarettes per day and period during the pregnancy) and alcohol consumption were collected from responses to direct questions during the medical examination.

2.2. Frequency of Food Consumed

A food frequency questionnaire to assess regular food intake was administered by a trained doctor to all participants in the third trimester before labour, as previously described [39]. The questionnaire was validated for estimated folate intake in the Mexican population. Briefly, the amount of food consumed was calculated in terms of the unit of measurement used (i.e., piece, cup, plate, or spoon) and the size of the unit (i.e., small, medium, or large). The frequency of consumption was calculated in grams or millilitres per day. The participants’ daily intake of energy (calories per day), macronutrients (carbohydrates, lipids, and proteins), and vitamins (A, C, and E) were calculated using the Food Processor SQL programme (version 10.9.0, 2011; ESHA Research, Salem, Oregon) and Mexican food tables, including data on traditional Mexican food [40]. For the statistical analysis, missing data on vitamins (n = 2) and calorie values above 2.5 standard deviation (SD) (n = 3) were excluded.

2.3. Blood Samples

During the last medical examination before delivery, 5 mL peripheral blood was collected from the women. Immediately after birth, the umbilical cord was clamped, and 5 mL blood samples were collected from it. All blood samples were collected in ethylenediaminetetraacetic acid-containing tubes, centrifuged at 1800× g/15 min, and subjected to protein precipitation with 20% trichloroacetic acid (50:50 v/v). Then, centrifugation was repeated at 3600× g/5 min at 4 °C. The plasma was stored at −80 °C until 8-OHdG determination.

2.4. 8-OHdG Quantification

The 8-OHdG level was determined in the plasma by immunofluorescence using the 8-hydroxy-2′-deoxyguanosine enzyme immunoassay (EIA) kit (CEDERLANE, Burlington, NC, USA) as previously reported [41]. Standard curves were constructed starting with a bulk standard of 8-OHdG (30 ng/mL, 8-hydroxy-2-deoxy Guanosine EIA Standard, Cat# CL89120KC) and 8 dilutions (3000 pg/mL to 10.3 pg/mL), and the assays were carried out according to the manufacturer’s instructions. Briefly, 50 μL of plasma, the EIA buffer, the 8-OHdG standard, and the 8-OHdG-acetylcholinesterase tracer were added to the wells. The monoclonal antibody against 8-OHdG was added, and the plate was incubated for 18 h at 4 °C followed by several washes with wash buffer. Then, 200 μL of Ellman’s reagent was added to each well. Optical densities were determined at 405 nm.

2.5. Clinical and Nutrient Profiles Based on 8-OHdG Tertiles

For the analysis, tertiles were constructed from the 8-OHdG values of the mothers and the newborns. For the mothers, tertile 1 was 1.55–3.09 ng/mL, tertile 2 was 3.13–4.23 ng/mL, and tertile 3 was 4.29–9.78 ng/mL, and for newborns, tertile 1 was 1.55–3.38 ng/mL, tertile 2 was 3.41–4.54 ng/mL, and tertile 3 was 4.59–12.83 ng/mL. Each tertile comprised 30 mothers and newborns (Figure 1). For micronutrients and macronutrients, the percentages of adequate intake were estimated using the recommended Dietary Reference Intakes from the Standing Committee On The Scientific Evaluation Of Dietary Reference Intakes (National Academy of Science, Washington, DC, USA) [42].

2.6. Statistical Analyses

Descriptive statistics, including mean, SD, median, interquartile range, and frequency, were used to describe the baseline characteristics of mothers and newborns. Medians and tertile ranges were used to report the daily calories obtained from the food consumed; amounts of proteins, carbohydrates, and fats; and the estimated consumption of vitamins A, C, and E. Based on a pre-exploratory variable analysis to identify their distributions, we used the Kruskal–Wallis rank sum test following a multiple comparison of p-values adjusted with the post-hoc Bonferroni method. Fisher’s exact test and the χ2 test were used to compare categorical variable differences. Quantile regression models were used to evaluate the association of clinical characteristics, macronutrients, and micronutrients with 8-OHdG levels. Data analysis and visualisation was performed in R version 3.6.2 (12 December 2019, Bell Laboratories, Murray Hill, NJ, USA) and STATA/SE 17.0 statistical programme (STATA Corp., College Station, TX, USA). p-values < 0.05 were considered to indicate statistically significant differences.

3. Results

3.1. Subject Characteristics

This study was performed with 90 women and their newborns. The mean age of the mothers was 24.1 ± 5.2 years, their mean pregestational weight was 63.8 ± 11.1 kg, and their mean pregestational BMI was 26.1 ± 4.0. Of them, 43.3% were normal-weight, 33.3% were overweight, and 23.3% were obese. Smoking during the first trimester of pregnancy was reported by 10% of the mothers, whereas only 1.1% (n = 1) reported alcohol consumption. Multivitamin supplements were consumed during pregnancy by 91.1% of women. The mean age of the newborns was 38.7 ± 1.3 weeks, their mean weight was 3188 ± 435 g, and their mean height was 49.4 ± 2.3 cm.
The characteristics of mothers and newborns for each 8-OHdG tertile are shown in Table 1. A significant proportion of normal-weight mothers were observed in tertile 1 compared with tertile 2 (p = 0.035). No other significant differences in clinical characteristics among mothers were observed.
Among the newborns classified by the tertiles for the mothers’ 8-OHdG levels, males were more frequent in tertile 1 than in tertile 2, and caesarean deliveries were more frequent in tertile 3 than in tertile 2. No other significant differences were observed in these groups (Table 1). On the other hand, among newborns classified according to the tertiles of their own 8-OHdG levels, newborns were significantly older in tertile 3 than in tertile 2, and caesarean deliveries were more frequent in tertile 1 than in tertile 2 (Table 1). No other significant differences were detected in the clinical characteristics of newborns in these groups.

3.2. Correlation of 8-OHdG Levels between Mothers and Newborns

We observed a strong correlation between the 8-OHdG levels of mothers and newborns (p < 0.001) (Figure 2). No significant correlations were detected between the 8-OHdG levels of mothers or newborns and the mothers’ age, pregestational weight, pregestational BMI, or the newborns’ age, weight, and height.

3.3. Nutritional Differences among Mother Tertiles in the Mothers 8-OHdG Group

Mothers in tertile 3 of the mothers 8-OHdG group consumed significantly lower amounts of calories, carbohydrates, lipids, proteins, and vitamin A, but not vitamin C and E, compared with mothers in tertile 1 (Table 2). No other significant differences were observed in macronutrient and micronutrient consumption by mothers belonging to these tertiles.

3.4. Nutritional Differences among the Mother Tertiles in the Newborns 8-OHdG Group

Mothers in tertile 3 of the newborns 8-OHdG group consumed significantly lower amounts of calories, carbohydrates, lipids, proteins, vitamins A and E, but not vitamin C, compared with mothers in tertile 1 (Table 3). Additionally, the mothers in tertile 2 consumed similar amounts of protein to those in tertile 3 (p > 0.05) but lower than those in tertile 1 (p < 0.05). Lastly, mothers in tertile 2 consumed more vitamin A than those in tertile 3 (p < 0.05), but similar to those in tertile 1 (p > 0.05). No other significant differences in macronutrient and micronutrient consumption were observed between the mothers in this group (Table 3).

3.5. Correlation of Mother Vitamins and Newborns 8-OHdG Levels

We observed significant correlations between vitamin A and vitamin E consumption by the mothers and 8-OHdG levels in the newborns (p < 0.001 and p = 0.007, respectively) (Figure 3a,b). A negative but no significant correlation between vitamin C for the mothers and the 8-OHdG levels of newborns was observed (Rho = −0.120, p = 0.257).

3.6. 8-OHdG Variation by BMI and Vitamin A Consumption

The levels of 8-OHdG in mothers and newborns decreased by a unit in mothers with pregestational obesity. Additionally, the 8-OHdG level in mothers decreased by one unit in tertile 3 of vitamin A consumption, while that in newborns decreased by one and two units in tertiles 2 and 3 of vitamin A consumption, respectively (Table 4). All variations of 8-OHdG were independent of caloric and vitamin intake.

4. Discussion

Pregnancy is characterised by increased OS [43], which is associated with metabolic activity and the development of the placenta [44]. DNA is especially susceptible to OS-mediated damage because guanines readily form adducts with FR giving rise to 8-OHdG [18]. During pregnancy, diet might increase or decrease OS, depending on its quality and quantity [17]; for example, the antioxidant properties of vitamins can keep OS in check [45].
In this work, the levels of 8-OHdG found in pregnant women and their newborns were similar to those reported previously [33,46,47,48]. Overweight and obesity in pregnant women have been associated with OS increment [49], OS-mediated DNA damage [50], and increased 8-OHdG levels [51]. However, when we compared the pregestational weight and BMI of mothers with their 8-OHdG levels (classified into tertiles), we did not observe significant associations (Table 1).
We observed that the 8-OHdG levels in mothers and newborns correlated strongly (Figure 2), which is in accordance with our previous study of another OS marker [39]. The source of 8-OHdG in pregnant women and newborns has not been identified yet [52], but Fukushima et al. showed that placental tissue stained positive for 8-OHdG [53]. Since the placenta has imperative functions, such as nutritional support and waste elimination [54], it might be an important, if not the major, source of 8-OHdG [30,52,55].
Maternal diet is an important regulator of OS since carbohydrate, lipid, and amino acid metabolism produces the superoxide radical (O2−), which through Haber–Weiss and Fenton’s reaction, produces hydrogen peroxide (H2O2) and the hydroxyl radical (•OH), respectively [56]. Consequently, over-nutrition increases OS production [57] and •OH and H2O2 induce 8-OHdG formation [58,59]. In our study, we expected a significant increment in 8-OHdG when food consumption was higher; however, we observed lower levels of 8-OHdG when the consumption of calories, carbohydrates, lipids, and proteins was higher (Table 2 and Table 3). This effect can only be explained by the antioxidant effects of the diet [60,61]. A study reported that daily fruit intake decreased urinary 8-OHdG secretion in adults [62], hinting that the antioxidant effects of vitamins might limit OS-mediated DNA damage [63]. Multiple studies have reported negative associations between different vitamins and 8-OHdG levels, e.g., plasma vitamin E levels and placental 8-OHdG [64], levels of vitamins E and C and 8-OHdG in the saliva of oral pre-cancer and cancer patients [65], serum vitamin C levels and urinary 8-OHdG [66], and plasma vitamin C levels and lymphocyte 8-OHdG levels in chronic renal disease [67].
To elucidate the effect of vitamins and maternal conditions on 8-OHdG levels, we developed beta analysis regressions. We found that obesity and the intake of vitamin A decreased 8-OHdG levels in mothers and newborns. This effect was maintained even after the analysis was adjusted for caloric intake, and it was more significant in the newborns (Table 4). This finding is contrary to a previous in vitro analysis, where vitamin A increased OS-mediated DNA damage with an increase in 8-oxo-7,8-dihydro-29-deoxyguanosine (8-oxodG) [68], another oxidated derivative of guanine. Nonetheless, vitamin A regulates approximately 532 genes, of which some are involved in antioxidant pathways (Cooper/Zink superoxide dismutase, manganese superoxide dismutase, and glutathione peroxidase 2) [69]. Although vitamin A increased OS-mediated DNA damage in vitro, antioxidant genes might be activated during in vivo OS regulation. The negative association of BMI with 8-OHdG levels might be explained by an increase in the bioavailability of vitamin A in obese people [70,71].
Ascorbic acid and vitamin E have been employed for the treatment of high oxidative conditions such as those found in cardiovascular disease [72], cancer [73], chronic kidney disease [74,75], obesity [76,77], T2D [78], and in smokers [79]. Nonetheless, the effects of vitamin C and E are still controversial since they might play pro-oxidant [80,81,82,83], antioxidant [80,84,85,86], or no [87,88] roles. Specifically, reports on the roles of vitamins E and C in preventing guanine oxidation are mixed [66,81,89]. In this study, vitamins E and C, alone or in combination, failed to reduce 8-OHdG levels. Antioxidant effects of these vitamins have been observed mainly in vitamin-deficient people but not in non-deficient people [66,90]. Interestingly, higher levels of 8-OHdG were observed when the intake of vitamins A and E, but not vitamin C, was lower, and vice versa (Table 2 and Table 3).
Alcohol consumption and smoking are common social practices, especially among young people [91]. In this study, we observed that 10% of women smoked until the first trimester of pregnancy, similar to reports for a Mexican-American population [40]. In some countries, as many as 25% of pregnant women smoke [92]. The proportion of smoking pregnant women in this study was similar to what was reported in a Spanish population [93]. Smoking is a prominent source of FR [94,95], which have deleterious effects on DNA [96,97], giving rise to 8-OHdG [98]. Smoking is associated with cardiovascular disease and cancer [99], and smoking during pregnancy has immediate or midterm effects on the foetus, including preterm pregnancy [100,101,102], low birth weight [102], congenital anomalies [103,104], chronic asthma [92,105,106,107], bronchiolitis [92,108], and psychiatric abnormalities [109,110,111,112]. Unfortunately, we could not follow the newborns of smoking mothers to confirm if they suffered from any of these conditions.
Predisposition to disease during adulthood has been associated with factors pertaining to the mother during the prenatal stage (foetal programming). Accordingly, we hypothesised that a diet rich in vitamins might modify the 8-OHdG levels during pregnancy in the mother–newborn binomial. Previous studies have proposed 8-OHdG as an OS maker in rheumatoid arthritis [48] and atherosclerotic plaque development [27], and as a risk factor for cardiovascular disease [29], metabolic syndrome [28], small-cell lung carcinoma [23], progression of hepatocellular carcinoma [22], and poor glycaemic control of T2D [21]. Consequently, higher levels of 8-OHdG in the progeny due to lower intake of vitamin-rich food by the mother might predispose the child to develop certain diseases in adulthood.
This study had some limitations. Since vitamin consumption was determined by a food frequency questionnaire, it was difficult to establish a precise and objective association between vitamins and 8-OHdG levels since factors like lower absorption rate [113], altered vitamin metabolism [114,115,116], or increased elimination rate [114,117] might modify the bioavailability of vitamins.

5. Conclusions

We found a strong correlation between 8-OHdG levels in mothers and newborns. The intake of vitamins A and E, but not C, by the mother might have a greater protective effects against OS-mediated DNA damage in newborns than in mothers.

Author Contributions

Conceptualisation, R.S.-U.; methodology, P.G.-R.; formal analysis, J.V.-G. and H.D.-G.; investigation, H.D.-G.; writing—original draft preparation, H.D.-G.; writing—review and editing, R.S.-U. and J.T.G.-R.; visualisation, M.K.-K.; supervision, J.G.-L.; funding acquisition, R.S.-U. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by an internal grant (Government Grant) from the Hospital Infantil de Mexico Federico Gómez, Mexico (Register Number: HIM/2016/031).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of the Hospital Infantil de Mexico Federico Gómez (Register Number: HIM/2016/031/25 January 2016).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The set of raw data analysed is available for other research studies upon application.

Acknowledgments

The author Hector Diaz-Garcia acknowledges the support of the Programa Nacional de Posgrados de Calidad of CONACyT Mexico (grant number: 420044) and the Beca de Estímulo Institucional de Formación de Investigadores program from the Instituto Politécnico Nacional (Mexico). The authors thank to the Department of Research of the Hospital Infantil of Mexico for their support for the development of this study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Alkerwi, A.A.; Vernier, C.; Sauvageot, N.; Crichton, G.E.; Elias, M.F. Demographic and socioeconomic disparity in nutrition: Application of a novel Correlated Component Regression approach. BMJ Open 2015, 5, e006814. [Google Scholar] [CrossRef] [PubMed]
  2. Koenig, M.D. Nutrient Intake During Pregnancy. J. Obstet. Gynecol. Neonatal Nurs. 2017, 46, 120–122. [Google Scholar] [CrossRef] [PubMed][Green Version]
  3. Desai, M.; Jellyman, J.K.; Ross, M.G. Epigenomics, gestational programming and risk of metabolic syndrome. Int. J. Obes. 2015, 39, 633–641. [Google Scholar] [CrossRef] [PubMed]
  4. Ruchat, S.-M.; Houde, A.-A.; Voisin, G.; St-Pierre, J.; Perron, P.; Baillargeon, J.-P.; Gaudet, D.; Hivert, M.-F.; Brisson, D.; Bouchard, L. Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics 2013, 8, 935–943. [Google Scholar] [CrossRef] [PubMed]
  5. Gagné-Ouellet, V.; Houde, A.A.; Guay, S.P. Placental lipoprotein lipase DNA methylation alterations are associated with gestational diabetes and body composition at 5 years of age. Epigenetics 2017, 12, 616–625. [Google Scholar] [CrossRef]
  6. Miyake, K.; Miyashita, C.; Ikeda-Araki, A.; Miura, R.; Itoh, S.; Yamazaki, K.; Kobayashi, S.; Masuda, H.; Ooka, T.; Yamagata, Z.; et al. DNA methylation of GFI1 as a mediator of the association between prenatal smoking exposure and ADHD symptoms at 6 years: The Hokkaido Study on Environment and Children’s Health. Clin. Epigenet. 2021, 13, 74. [Google Scholar] [CrossRef]
  7. Küpers, L.K.; Xu, X.; Jankipersadsing, S.A.; Vaez, A.; la Bastide-van Gemert, S.; Scholtens, S.; Nolte, I.M.; Richmond, R.C.; Relton, C.L.; Felix, J.F.; et al. DNA methylation mediates the effect of maternal smoking during pregnancy on birthweight of the offspring. Int. J. Epidemiol. 2015, 44, 1224–1237. [Google Scholar] [CrossRef]
  8. Sarkar, D.K.; Gangisetty, O.; Wozniak, J.R.; Eckerle, J.K.; Georgieff, M.K.; Foroud, T.M.; Wetherill, L. Persistent Changes in Stress-Regulatory Genes in Pregnant Women or Children Exposed Prenatally to Alcohol. Alcohol. Clin. Exp. Res. 2019, 43, 1887–1897. [Google Scholar] [CrossRef]
  9. Breton-Larrivée, M.; Elder, E.; McGraw, S. DNA methylation, environmental exposures and early embryo development. Anim. Reprod. 2019, 16, 465–474. [Google Scholar] [CrossRef]
  10. Urbaniak, S.K.; Boguszewska, K. 8-Oxo-7,8-Dihydro-2′-Deoxyguanosine (8-oxodG) and 8-Hydroxy-2′-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development. Molecules 2020, 25, 202. [Google Scholar] [CrossRef]
  11. García-Sánchez, A.; Miranda-Díaz, A.G.; Cardona-Muñoz, E.G. The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases. Oxid. Med. Cell. Longev. 2020, 2020, 2082145. [Google Scholar] [CrossRef] [PubMed]
  12. Jat, D.; Nahar, M. Oxidative stress and antioxidants: An overview. IJARR 2017, 2, 110–119. [Google Scholar]
  13. Venereo Gutiérrez, J.R. Daño oxidativo, radicales libres y antioxidantes. Rev. Cuba. Med. Mil. 2002, 31, 126–133. [Google Scholar]
  14. Savini, I.; Gasperi, V.; Catani, M.V. Oxidative Stress and Obesity. In Obesity: A Practical Guide; Ahmad, S.I., Imam, S.K., Eds.; Springer International Publishing: Cham, Switzerland, 2016; pp. 65–86. [Google Scholar]
  15. Domej, W.; Oettl, K.; Renner, W. Oxidative stress and free radicals in COPD—Implications and relevance for treatment. Int. J. Chronic Obstr. Pulm. Dis. 2014, 2014, 1207–1224. [Google Scholar] [CrossRef] [PubMed]
  16. Dennery, P.A. Effects of oxidative stress on embryonic development. Birth Defects Res. Part C Embryo Today Rev. 2007, 81, 155–162. [Google Scholar] [CrossRef] [PubMed]
  17. Luo, Z.C.; Fraser, W.D.; Julien, P.; Deal, C.L.; Audibert, F.; Smith, G.N.; Xiong, X.; Walker, M. Tracing the origins of “fetal origins” of adult diseases: Programming by oxidative stress? Med. Hypotheses 2006, 66, 38–44. [Google Scholar] [CrossRef] [PubMed]
  18. Cadet, J.; Wagner, J.R.; Shafirovich, V.; Geacintov, N.E. One-electron oxidation reactions of purine and pyrimidine bases in cellular DNA. Int. J. Radiat. Biol. 2014, 90, 423–432. [Google Scholar] [CrossRef]
  19. Asami, S.; Manabe, H.; Miyake, J.; Tsurudome, Y.; Hirano, T.; Yamaguchi, R.; Itoh, H.; Kasai, H. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 1997, 18, 1763–1766. [Google Scholar] [CrossRef]
  20. Thomas, M.C.; Woodward, M.; Li, Q.; Pickering, R.; Tikellis, C.; Poulter, N.; Cooper, M.E.; Marre, M.; Zoungas, S.; Chalmers, J. Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results from the ADVANCE Trial. J. Am. Heart Assoc. 2018, 7, e008226. [Google Scholar] [CrossRef]
  21. Leinonen, J.; Lehtimäki, T.; Toyokuni, S.; Okada, K.; Tanaka, T.; Hiai, H.; Ochi, H.; Laippala, P.; Rantalaiho, V.; Wirta, O.; et al. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett. 1997, 417, 150–152. [Google Scholar] [CrossRef]
  22. Chuma, M.; Hige, S.; Nakanishi, M.; Ogawa, K.; Natsuizaka, M.; Yamamoto, Y.; Asaka, M. 8-Hydroxy-2′-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J. Gastroenterol. Hepatol. 2008, 23, 1431–1436. [Google Scholar] [CrossRef] [PubMed]
  23. Erhola, M.; Toyokuni, S.; Okada, K.; Tanaka, T.; Hiai, H.; Ochi, H.; Uchida, K.; Osawa, T.; Nieminen, M.M.; Alho, H.; et al. Biomarker evidence of DNA oxidation in lung cancer patients: Association of urinary 8-hydroxy-2′-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett. 1997, 409, 287–291. [Google Scholar] [CrossRef]
  24. Liu, Z.; Cai, Y.; He, J. High serum levels of 8-OHdG are an independent predictor of post-stroke depression in Chinese stroke survivors. Neuropsychiatr. Dis. Treat. 2018, 14, 587–596. [Google Scholar] [CrossRef] [PubMed]
  25. Chen, Y.-C.; Chen, C.-M.; Liu, J.-L.; Chen, S.-T.; Cheng, M.-L.; Chiu, D.T.-Y. Oxidative markers in spontaneous intracerebral hemorrhage: Leukocyte 8-hydroxy-2′-deoxyguanosine as an independent predictor of the 30-day outcome. J. Neurosurg. 2011, 115, 1184–1190. [Google Scholar] [CrossRef] [PubMed]
  26. Iida, T.; Inoue, K.; Ito, Y.; Ishikawa, H.; Kagiono, M.; Teradaira, R.; Chikamura, C.; Harada, T.; Ezoe, S.; Yatsuya, H. Comparison of urinary levels of 8-hydroxy-2′-deoxyguanosine between young females with and without depressive symptoms during different menstrual phases. Acta Med. Okayama 2015, 69, 45–50. [Google Scholar] [CrossRef] [PubMed]
  27. Martinet, W.; Knaapen, M.W.; De Meyer, G.R.; Herman, A.G.; Kockx, M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002, 106, 927–932. [Google Scholar] [CrossRef] [PubMed]
  28. Miyamoto, M.; Kotani, K.; Ishibashi, S.; Taniguchi, N. The relationship between urinary 8-hydroxydeoxyguanosine and metabolic risk factors in asymptomatic subjects. Med. Princ. Pract. Int. J. Kuwait Univ. Health Sci. Cent. 2011, 20, 187–190. [Google Scholar] [CrossRef]
  29. Satoh, M.; Ishikawa, Y.; Takahashi, Y.; Itoh, T.; Minami, Y.; Nakamura, M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 2008, 198, 347–353. [Google Scholar] [CrossRef]
  30. Min, J.; Park, B.; Kim, Y.J.; Lee, H.; Ha, E.; Park, H. Effect of oxidative stress on birth sizes: Consideration of window from mid pregnancy to delivery. Placenta 2009, 30, 418–423. [Google Scholar] [CrossRef]
  31. Murata, T.; Kyozuka, H.; Fukuda, T.; Endo, Y.; Kanno, A.; Yasuda, S.; Yamaguchi, A.; Sato, A.; Ogata, Y.; Shinoki, K.; et al. Urinary 8-hydroxy-2′-deoxyguanosine levels and small-for-gestational age infants: A prospective cohort study from the Japan Environment and Children’s Study. BMJ Open 2021, 11, e054156. [Google Scholar] [CrossRef]
  32. Yuan, Y.; Zhang, L.; Jin, L.; Liu, J.; Li, Z.; Wang, L.; Ren, A. Markers of macromolecular oxidative damage in maternal serum and risk of neural tube defects in offspring. Free Radic. Biol. Med. 2015, 80, 27–32. [Google Scholar] [CrossRef] [PubMed]
  33. Hozyasz, K.K.; Chełchowska, M.; Ambroszkiewicz, J.; Gajewska, J.; Dudkiewicz, Z.; Laskowska-Klita, T. Oxidative DNA damage in mothers of children with isolated orofacial clefts. Prz. Lek. 2004, 61, 1310–1313. [Google Scholar]
  34. Qiu, C.; Hevner, K.; Abetew, D.; Enquobahrie, D.A.; Williams, M.A. Oxidative DNA damage in early pregnancy and risk of gestational diabetes mellitus: A pilot study. Clin. Biochem. 2011, 44, 804–808. [Google Scholar] [CrossRef] [PubMed]
  35. Gelaleti, R.B.; Damasceno, D.C.; Lima, P.H.O.; Salvadori, D.M.F.; Calderon, I.d.M.P.; Peraçoli, J.C.; Rudge, M.V.C. Oxidative DNA damage in diabetic and mild gestational hyperglycemic pregnant women. Diabetol. Metab. Syndr. 2015, 7, 1. [Google Scholar] [CrossRef] [PubMed]
  36. Moreno-Fernandez, J.; Ochoa, J.J. COVID-19 during Gestation: Maternal Implications of Evoked Oxidative Stress and Iron Metabolism Impairment. Antioxidants 2022, 11, 184. [Google Scholar] [CrossRef]
  37. Olorunnisola, O.; Ajayi, A.; Okeleji, L.; Abimbola, O.; Emorioloye, J. Vitamins as Antioxidants. J. Food Sci. Nutr. Res. 2019, 2, 214–235. [Google Scholar] [CrossRef]
  38. Lee, B.M.; Lee, S.K.; Kim, H.S. Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, β-carotene and red ginseng). Cancer Lett. 1998, 132, 219–227. [Google Scholar] [CrossRef]
  39. Lopez-Yañez Blanco, A.; Díaz-López, K.M.; Vilchis-Gil, J.; Diaz-Garcia, H.; Gomez-Lopez, J.; Medina-Bravo, P.; Granados-Riveron, J.T.; Gallardo, J.M.; Klünder-Klünder, M.; Sánchez-Urbina, R. Diet and Maternal Obesity Are Associated with Increased Oxidative Stress in Newborns: A Cross-Sectional Study. Nutrients 2022, 14, 746. [Google Scholar] [CrossRef]
  40. Bandiera, F.C.; Pérez-Stable, E.J.; Atem, F.; Caetano, R.; Vidot, D.C.; Gellman, M.D.; Navas-Nacher, E.L.; Cai, J.; Talavera, G.; Schneiderman, N.; et al. At risk alcohol consumption with smoking by national background: Results from the Hispanic community health study/study of Latinos. Addict. Behav. 2019, 99, 106087. [Google Scholar] [CrossRef]
  41. Castilla-Peon, M.F.; Bravo, P.G.M.; Sánchez-Urbina, R.; Gallardo-Montoya, J.M.; Soriano-López, L.C.; Cruz, F.M.C. Diabetes and obesity during pregnancy are associated with oxidative stress genotoxicity in newborns. J. Perinat. Med. 2019, 47, 347–353. [Google Scholar] [CrossRef]
  42. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and Its Panel on Folate, Other B Vitamins, and Choline; National Academy of Sciences: Washington, DC, USA, 1998.
  43. Toescu, V.; Nuttall, S.L.; Martin, U.; Kendall, M.J.; Dunne, F. Oxidative stress and normal pregnancy. Clin. Endocrinol. 2002, 57, 609–613. [Google Scholar] [CrossRef] [PubMed]
  44. Toboła-Wróbel, K.; Pietryga, M.; Dydowicz, P.; Napierała, M.; Brązert, J.; Florek, E. Association of Oxidative Stress on Pregnancy. Oxid. Med. Cell. Longev. 2020, 2020, 6398520. [Google Scholar] [CrossRef] [PubMed]
  45. Mistry, H.D.; Williams, P.J. The importance of antioxidant micronutrients in pregnancy. Oxid. Med. Cell. Longev. 2011, 2011, 841749. [Google Scholar] [CrossRef] [PubMed]
  46. Ebina, S.; Chiba, T.; Ozaki, T.; Kashiwakura, I. Relationship between 8-hydroxydeoxyguanosine levels in placental/umbilical cord blood and maternal/neonatal obstetric factors. Exp. Ther. Med. 2012, 4, 387–390. [Google Scholar] [CrossRef] [PubMed][Green Version]
  47. Stadem, P.S.; Hilgers, M.V.; Bengo, D.; Cusick, S.E.; Ndidde, S.; Slusher, T.M.; Lund, T.C. Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns. PLoS ONE 2017, 12, e0172980. [Google Scholar] [CrossRef] [PubMed]
  48. Seven, A.; Güzel, S.; Aslan, M.; Hamuryudan, V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin. Biochem. 2008, 41, 538–543. [Google Scholar] [CrossRef]
  49. Gallardo, J.M.; Gómez-López, J.; Medina-Bravo, P.; Juárez-Sánchez, F.; Contreras-Ramos, A.; Galicia-Esquivel, M.; Sánchez-Urbina, R.; Klünder-Klünder, M. Maternal obesity increases oxidative stress in the newborn. Obesity 2015, 23, 1650–1654. [Google Scholar] [CrossRef]
  50. Cooke, M.S.; Evans, M.D.; Dizdaroglu, M.; Lunec, J. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2003, 17, 1195–1214. [Google Scholar] [CrossRef]
  51. Al-Aubaidy, H.A.; Jelinek, H.F. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur. J. Endocrinol. 2011, 164, 899–904. [Google Scholar] [CrossRef]
  52. Schulpis, K.H.; Lazaropoulou, C.; Vlachos, G.D.; Partsinevelos, G.A.; Michalakakou, K.; Gavrili, S.; Gounaris, A.; Antsaklis, A.; Papassotiriou, I. Maternal-neonatal 8-hydroxy-deoxyguanosine serum concentrations as an index of DNA oxidation in association with the mode of labour and delivery. Acta Obstet. Gynecol. Scand. 2007, 86, 320–326. [Google Scholar] [CrossRef]
  53. Fukushima, K.; Murata, M.; Tsukimori, K.; Eisuke, K.; Wake, N. 8-Hydroxy-2-deoxyguanosine staining in placenta is associated with maternal serum uric acid levels and gestational age at diagnosis in pre-eclampsia. Am. J. Hypertens. 2011, 24, 829–834. [Google Scholar] [CrossRef] [PubMed]
  54. Maccani, J.Z.; Maccani, M.A. Altered placental DNA methylation patterns associated with maternal smoking: Current perspectives. Adv. Genom. Genet. 2015, 2015, 205–214. [Google Scholar] [CrossRef] [PubMed]
  55. Rossner, P., Jr.; Milcova, A.; Libalova, H.; Novakova, Z.; Topinka, J.; Balascak, I.; Sram, R.J. Biomarkers of exposure to tobacco smoke and environmental pollutants in mothers and their transplacental transfer to the foetus. Part II. Oxidative damage. Mutat. Res. 2009, 669, 20–26. [Google Scholar] [CrossRef] [PubMed]
  56. Al-Gubory, K.H. Maternal Nutrition, Oxidative Stress and Prenatal Devlopmental Outcomes. In Studies on Women’s Health; Agarwal, A., Aziz, N., Rizk, B., Eds.; Humana Press: Totowa, NJ, USA, 2013; pp. 1–31. [Google Scholar]
  57. Boden, G.; Homko, C.; Barrero, C.A.; Stein, T.P.; Chen, X.; Cheung, P.; Fecchio, C.; Koller, S.; Merali, S. Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men. Sci. Transl. Med. 2015, 7, 304re7. [Google Scholar] [CrossRef]
  58. Fischer-Nielsen, A.; Jeding, I.B.; Loft, S. Radiation-induced formation of 8-hydroxy-2′-deoxyguanosine and its prevention by scavengers. Carcinogenesis 1994, 15, 1609–1612. [Google Scholar] [CrossRef]
  59. Abu-Shakra, A.; Zeiger, E. Formation of 8-hydroxy-2′-deoxyguanosine following treatment of 2′-deoxyguanosine or DNA by hydrogen peroxide or glutathione. Mutat. Res. 1997, 390, 45–50. [Google Scholar] [CrossRef]
  60. Block, G.; Wakimoto, P.; Jensen, C.; Mandel, S.; Green, R.R. Validation of a food frequency questionnaire for Hispanics. Prev. Chronic Dis. 2006, 3, A77. [Google Scholar]
  61. Terminel-Zaragoza, R.; Vega-López, S.; Ulloa-Mercado, G.; Serna-Gutiérrez, A.; Gortáres-Moroyoqui, P.; Díaz, L.; Rentería-Mexía, A. Reproducibility and validity of a food frequency questionnaire to assess cardiovascular health-related food intake among Mexican adolescents. J. Nutr. Sci. 2022, 11, e3. [Google Scholar] [CrossRef]
  62. Tamae, K.; Kawai, K.; Yamasaki, S.; Kawanami, K.; Ikeda, M.; Takahashi, K.; Miyamoto, T.; Kato, N.; Kasai, H. Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxydeoxyguanosine. Cancer Sci. 2009, 100, 715–721. [Google Scholar] [CrossRef]
  63. Guo, X.; Cui, H.; Zhang, H.; Guan, X.; Zhang, Z.; Jia, C.; Wu, J.; Yang, H.; Qiu, W.; Zhang, C.; et al. Protective Effect of Folic Acid on Oxidative DNA Damage: A Randomized, Double-Blind, and Placebo Controlled Clinical Trial. Medicine 2015, 94, e1872. [Google Scholar] [CrossRef]
  64. Daube, H.; Scherer, G.; Riedel, K.; Ruppert, T.; Tricker, A.R.; Rosenbaum, P.; Adlkofer, F. DNA adducts in human placenta in relation to tobacco smoke exposure and plasma antioxidant status. J. Cancer Res. Clin. Oncol. 1997, 123, 141–151. [Google Scholar] [CrossRef] [PubMed]
  65. Kaur, J.; Politis, C.; Jacobs, R. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: Diagnostic value and free radical mechanism of action. Clin. Oral Investig. 2016, 20, 315–319. [Google Scholar] [CrossRef] [PubMed]
  66. Huang, H.Y.; Helzlsouer, K.J.; Appel, L.J. The effects of vitamin C and vitamin E on oxidative DNA damage: Results from a randomized controlled trial. Cancer Epidemiol. Biomark. Prev. A Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 2000, 9, 647–652. [Google Scholar]
  67. Tarng, D.-C.; Liu, T.-Y.; Huang, T.-P. Protective effect of vitamin C on 8-hydroxy-2′-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients. Kidney Int. 2004, 66, 820–831. [Google Scholar] [CrossRef]
  68. Murata, M.; Kawanishi, S. Oxidative DNA Damage by Vitamin A and Its Derivative via Superoxide Generation. J. Biol. Chem. 2000, 275, 2003–2008. [Google Scholar] [CrossRef]
  69. Balmer, J.E.; Blomhoff, R. Gene expression regulation by retinoic acid. J. Lipid Res. 2002, 43, 1773–1808. [Google Scholar] [CrossRef]
  70. Olsen, T.; Blomhoff, R. Retinol, Retinoic Acid, and Retinol-Binding Protein 4 are Differentially Associated with Cardiovascular Disease, Type 2 Diabetes, and Obesity: An Overview of Human Studies. Adv. Nutr. 2020, 11, 644–666. [Google Scholar] [CrossRef]
  71. Graham, T.E.; Yang, Q.; Blüher, M.; Hammarstedt, A.; Ciaraldi, T.P.; Henry, R.R.; Wason, C.J.; Oberbach, A.; Jansson, P.-A.; Smith, U.; et al. Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects. N. Engl. J. Med. 2006, 354, 2552–2563. [Google Scholar] [CrossRef]
  72. Padayatty, S.J.; Levine, M. Antioxidant supplements and cardiovascular disease in men. JAMA 2009, 301, 1336. [Google Scholar] [CrossRef]
  73. Coulter, I.D.; Hardy, M.L.; Morton, S.C.; Hilton, L.G.; Tu, W.; Valentine, D.; Shekelle, P.G. Antioxidants Vitamin C and Vitamin E for the Prevention and Treatment of Cancer. J. Gen. Intern. Med. 2006, 21, 735–744. [Google Scholar] [CrossRef]
  74. Deicher, R.; Hörl, W.H. Vitamin C in chronic kidney disease and hemodialysis patients. Kidney Blood Press. Res. 2003, 26, 100–106. [Google Scholar] [CrossRef] [PubMed]
  75. Rezaei, Y.; Khademvatani, K.; Rahimi, B.; Khoshfetrat, M.; Arjmand, N.; Seyyed-Mohammadzad, M.-H. Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients with Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial. J. Am. Heart Assoc. 2016, 5, e002919. [Google Scholar] [CrossRef] [PubMed]
  76. Garcia-Diaz, D.F.; Lopez-Legarrea, P.; Quintero, P.; Martinez, J.A. Vitamin C in the treatment and/or prevention of obesity. J. Nutr. Sci. Vitaminol. 2014, 60, 367–379. [Google Scholar] [CrossRef] [PubMed]
  77. Hendarto, A.; Alhadar, A.K.; Sjarif, D.R. The Effect of Vitamin E Supplementation on Lipid Profiles and Adiponectin Levels in Obese Adolescents: A Randomized Controlled Trial. Acta Med. Indones. 2019, 51, 110–116. [Google Scholar]
  78. Garcia-Bailo, B.; El-Sohemy, A.; Haddad, P.S.; Arora, P.; Benzaied, F.; Karmali, M.; Badawi, A. Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: Modulation of inflammation and oxidative stress. Biol. Targets Ther. 2011, 5, 7–19. [Google Scholar] [CrossRef]
  79. Ismail, N.M.; Harun, A.; Yusof, A.A.; Zaiton, Z.; Marzuki, A. Role of vitamin e on oxidative stress in smokers. Malays. J. Med. Sci. 2002, 9, 34–42. [Google Scholar]
  80. Kaźmierczak-Barańska, J.; Boguszewska, K.; Adamus-Grabicka, A.; Karwowski, B.T. Two Faces of Vitamin C-Antioxidative and Pro-Oxidative Agent. Nutrients 2020, 12, 1501. [Google Scholar] [CrossRef]
  81. Podmore, I.D.; Griffiths, H.R.; Herbert, K.E.; Mistry, N.; Mistry, P.; Lunec, J. Vitamin C exhibits pro-oxidant properties. Nature 1998, 392, 559. [Google Scholar] [CrossRef]
  82. Pearson, P.; Lewis, S.A.; Britton, J.; Young, I.S.; Fogarty, A. The pro-oxidant activity of high-dose vitamin E supplements in vivo. BioDrugs Clin. Immunother. Biopharm. Gene Ther. 2006, 20, 271–273. [Google Scholar] [CrossRef]
  83. Weinberg, R.B.; VanderWerken, B.S.; Anderson, R.A.; Stegner, J.E.; Thomas, M.J. Pro-Oxidant Effect of Vitamin E in Cigarette Smokers Consuming a High Polyunsaturated Fat Diet. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1029–1033. [Google Scholar] [CrossRef]
  84. Rendón-Ramírez, A.; Maldonado-Vega, M.; Quintanar-Escorza, M.; Hernández, G.; Arévalo, B.; Zentella-Dehesa, A.; Calderón-Salinas, J.-V. Effect of vitamin E and C supplementation on oxidative damage and total antioxidant capacity in lead-exposed workers. Environ. Toxicol. Pharmacol. 2014, 37, 45–54. [Google Scholar] [CrossRef] [PubMed]
  85. Prajapat, R.; Bhattacharya, I. Effect of Vitamin E and C Supplementation on Oxidative Stress in Diabetic Patients. Adv. Diabetes Metab. 2017, 5, 39–42. [Google Scholar] [CrossRef]
  86. Brown, K.M.; Morrice, P.C.; Duthie, G.G. Erythrocyte vitamin E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and nonsmokers: Dose response to vitamin E supplementation. Am. J. Clin. Nutr. 1997, 65, 496–502. [Google Scholar] [CrossRef] [PubMed]
  87. Bader, N.; Bosy-Westphal, A.; Koch, A.; Mueller, M.J. Influence of vitamin C and E supplementation on oxidative stress induced by hyperbaric oxygen in healthy men. Ann. Nutr. Metab. 2006, 50, 173–176. [Google Scholar] [CrossRef] [PubMed]
  88. Bader, N.; Bosy-Westphal, A.; Koch, A.; Rimbach, G.; Weimann, A.; Poulsen, H.E.; Müller, M.J. Effect of hyperbaric oxygen and vitamin C and E supplementation on biomarkers of oxidative stress in healthy men. Br. J. Nutr. 2007, 98, 826–833. [Google Scholar] [CrossRef]
  89. Lutsenko, E.A.; Cárcamo, J.M.; Golde, D.W. Vitamin C prevents DNA mutation induced by oxidative stress. J. Biol. Chem. 2002, 277, 16895–16899. [Google Scholar] [CrossRef]
  90. Guarnieri, S.; Loft, S.; Riso, P.; Porrini, M.; Risom, L.; Poulsen, H.E.; Dragsted, L.O.; Møller, P. DNA repair phenotype and dietary antioxidant supplementation. Br. J. Nutr. 2008, 99, 1018–1024. [Google Scholar] [CrossRef]
  91. Bobo, J.K.; Husten, C. Sociocultural influences on smoking and drinking. Alcohol Res. Health J. Natl. Inst. Alcohol Abus. Alcohol. 2000, 24, 225–232. [Google Scholar]
  92. McEvoy, C.T.; Spindel, E.R. Pulmonary Effects of Maternal Smoking on the Fetus and Child: Effects on Lung Development, Respiratory Morbidities, and Life Long Lung Health. Paediatr. Respir. Rev. 2017, 21, 27–33. [Google Scholar] [CrossRef]
  93. Corrales-Gutierrez, I.; Baena-Antequera, F.; Gomez-Baya, D.; Leon-Larios, F.; Mendoza, R. Relationship between Eating Habits, Physical Activity and Tobacco and Alcohol Use in Pregnant Women: Sociodemographic Inequalities. Nutrients 2022, 14, 557. [Google Scholar] [CrossRef]
  94. Vadhanam, M.V.; Thaiparambil, J.; Gairola, C.G.; Gupta, R.C. Oxidative DNA Adducts Detected in Vitro from Redox Activity of Cigarette Smoke Constituents. Chem. Res. Toxicol. 2012, 25, 2499–2504. [Google Scholar] [CrossRef] [PubMed]
  95. Pryor, W.A. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ. Health Perspect. 1997, 105 (Suppl. S4), 875–882. [Google Scholar] [CrossRef] [PubMed]
  96. Cantin, A.M. Cellular Response to Cigarette Smoke and Oxidants. Proc. Am. Thorac. Soc. 2010, 7, 368–375. [Google Scholar] [CrossRef] [PubMed]
  97. Lobo, V.; Patil, A.; Phatak, A.; Chandra, N. Free radicals, antioxidants and functional foods: Impact on human health. Pharm. Rev. 2010, 4, 118–126. [Google Scholar] [CrossRef] [PubMed]
  98. Cao, C.; Lai, T.; Li, M.; Zhou, H.; Lv, D.; Deng, Z.; Ying, S.; Chen, Z.; Li, W.; Shen, H. Smoking-promoted oxidative DNA damage response is highly correlated to lung carcinogenesis. Oncotarget 2016, 7, 18919–18926. [Google Scholar] [CrossRef] [PubMed]
  99. Jha, P. Avoidable global cancer deaths and total deaths from smoking. Nat. Rev. Cancer 2009, 9, 655–664. [Google Scholar] [CrossRef]
  100. Nabet, C.; Ancel, P.-Y.; Burguet, A.; Kaminski, M. Smoking during pregnancy and preterm birth according to obstetric history: French national perinatal surveys. Paediatr. Perinat. Epidemiol. 2005, 19, 88–96. [Google Scholar] [CrossRef]
  101. Kyrklund-Blomberg, N.B.; Granath, F.; Cnattingius, S. Maternal smoking and causes of very preterm birth. Acta Obstet. Gynecol. Scand. 2005, 84, 572–577. [Google Scholar] [CrossRef]
  102. Steyn, K.; de Wet, T.; Saloojee, Y.; Nel, H.; Yach, D. The influence of maternal cigarette smoking, snuff use and passive smoking on pregnancy outcomes: The Birth to Ten Study. Paediatr. Perinat. Epidemiol. 2006, 20, 90–99. [Google Scholar] [CrossRef]
  103. Alverson, C.J.; Strickland, M.J.; Gilboa, S.M.; Correa, A. Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics 2011, 127, e647–e653. [Google Scholar] [CrossRef]
  104. García-Villarino, M.; Fernández-Iglesias, R. Prenatal Exposure to Cigarette Smoke and Anogenital Distance at 4 Years in the INMA-Asturias Cohort. Int. J. Environ. Res. Public Health 2021, 18, 4774. [Google Scholar] [CrossRef] [PubMed]
  105. Zlotkowska, R.; Zejda, J.E. Fetal and postnatal exposure to tobacco smoke and respiratory health in children. Eur. J. Epidemiol. 2005, 20, 719–727. [Google Scholar] [CrossRef] [PubMed]
  106. Lannerö, E.; Wickman, M.; Pershagen, G.; Nordvall, L. Maternal smoking during pregnancy increases the risk of recurrent wheezing during the first years of life (BAMSE). Respir. Res. 2006, 7, 3. [Google Scholar] [CrossRef] [PubMed]
  107. Bjerg, A.; Hedman, L.; Perzanowski, M.; Lundbäck, B.; Rönmark, E. A strong synergism of low birth weight and prenatal smoking on asthma in schoolchildren. Pediatrics 2011, 127, e905–e912. [Google Scholar] [CrossRef] [PubMed]
  108. Taylor, B.; Wadsworth, J. Maternal smoking during pregnancy and lower respiratory tract illness in early life. Arch. Dis. Child. 1987, 62, 786–791. [Google Scholar] [CrossRef]
  109. Ekblad, M.; Lehtonen, L.; Korkeila, J.; Gissler, M. Maternal Smoking During Pregnancy and the Risk of Psychiatric Morbidity in Singleton Sibling Pairs. Nicotine Tob. Res. Off. J. Soc. Res. Nicotine Tob. 2017, 19, 597–604. [Google Scholar] [CrossRef]
  110. Sourander, A.; Sucksdorff, M.; Chudal, R.; Surcel, H.M.; Hinkka-Yli-Salomäki, S.; Gyllenberg, D.; Cheslack-Postava, K.; Brown, A.S. Prenatal Cotinine Levels and ADHD Among Offspring. Pediatrics 2019, 143, e20183144. [Google Scholar] [CrossRef]
  111. Kovess, V.; Keyes, K.M.; Hamilton, A.; Pez, O.; Bitfoi, A.; Koç, C.; Goelitz, D.; Kuijpers, R.; Lesinskiene, S.; Mihova, Z.; et al. Maternal smoking and offspring inattention and hyperactivity: Results from a cross-national European survey. Eur. Child Adolesc. Psychiatry 2015, 24, 919–929. [Google Scholar] [CrossRef]
  112. Brannigan, R.; Tanskanen, A.; Huttunen, M.O.; Cannon, M.; Leacy, F.P.; Clarke, M.C. Maternal smoking during pregnancy and offspring psychiatric disorder: A longitudinal birth cohort study. Soc. Psychiatry Psychiatr. Epidemiol. 2022, 57, 595–600. [Google Scholar] [CrossRef]
  113. Krall, E.A.; Dawson-Hughes, B. Smoking increases bone loss and decreases intestinal calcium absorption. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 1999, 14, 215–220. [Google Scholar] [CrossRef]
  114. Linnell, J.C.; Smith, A.D.; Smith, C.L.; Wilson, J.; Matthews, D.M. Effects of smoking on metabolism and excretion of vitamin B12. Br. Med. J. 1968, 2, 215–216. [Google Scholar] [CrossRef] [PubMed]
  115. Brot, C.; Jorgensen, N.R.; Sorensen, O.H. The influence of smoking on vitamin D status and calcium metabolism. Eur. J. Clin. Nutr. 1999, 53, 920–926. [Google Scholar] [CrossRef] [PubMed]
  116. Sealey, W.M.; Teague, A.M.; Stratton, S.L.; Mock, D.M. Smoking accelerates biotin catabolism in women. Am. J. Clin. Nutr. 2004, 80, 932–935. [Google Scholar] [CrossRef] [PubMed]
  117. Bruno, R.S.; Ramakrishnan, R.; Montine, T.J.; Bray, T.M.; Traber, M.G. α-Tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status. Am. J. Clin. Nutr. 2005, 81, 95–103. [Google Scholar] [CrossRef] [PubMed]
Life 12 01012 g001
Figure 1. Group distribution by tertile of the 8-OHdG levels of mothers and newborns for nutritional analysis. 8-OHdG, 8-hydroxy-2′-deoxy-guanosine.
Figure 1. Group distribution by tertile of the 8-OHdG levels of mothers and newborns for nutritional analysis. 8-OHdG, 8-hydroxy-2′-deoxy-guanosine.
Life 12 01012 g001
Life 12 01012 g002
Figure 2. Correlation between the 8-OHdG concentrations of mothers and newborns.
Figure 2. Correlation between the 8-OHdG concentrations of mothers and newborns.
Life 12 01012 g002
Life 12 01012 g003
Figure 3. Correlation between vitamin A (a) and vitamin E (b) consumption by the mothers and 8-OHdG levels in the newborns.
Figure 3. Correlation between vitamin A (a) and vitamin E (b) consumption by the mothers and 8-OHdG levels in the newborns.
Life 12 01012 g003
Table 1. Clinical features of mothers and newborns for each 8-OHdG tertile.
Table 1. Clinical features of mothers and newborns for each 8-OHdG tertile.
MothersMothers 8-OHdGp-ValueNewborns 8-OHdGp-Value
Tertile 1 Mean ± SDTertile 2 Mean ± SDTertile 3 Mean ± SDabcTertile 1 Mean ± SDTertile 2 Mean ± SDTertile 3 Mean ± SDabc
Age (years) §23.1 ± 6.224.7 ± 4.924.6 ± 4.50.2500.301123.0 ± 5.625.4 ± 5.824.0 ± 4.00.1640.9191
Pregestational weight (kg) §61.0 ± 12.166.1 ± 10.564.4 ± 10.30.1670.595161.5 ± 11.267.3 ± 10.862.8 ± 10.70.08510.392
Pregestational BMI (kg/m2) §24.9 ± 4.427.2 ± 3.926.1 ± 3.50.1560.950125.8 ± 4.427.1 ± 4.225.4 ± 3.40.92910.432
Normal-weight (n, %) §§17 (56.7)8 (26.7)14 (46.7)0.0350.6050.17916 (53.3)10 (33.3)13 (43.3)0.1920.6050.595
Overweight (n, %) §§7 (23.3)13 (43.3)10 (33.3)0.1700.5670.5956 (20.0)11 (36.7)13 (43.3)0.2510.0940.792
Obese (n, %) §§6 (20.0)9 (30.0)6 (20.0)0.55210.5528 (26.7)9 (30.0)4 (13.3)10.3330.209
Smoking (n, %)6 (20.0)3 (10.0)0---8 (26.7)1 (3.3)0---
Multivitamin suppl. (n, %) §§§26 (86.7)28 (93.3)28 (93.3)0.6670.667127 (90.0)28 (93.3)27 (90.0)111
Newborns
Gestational age (weeks) §38.8 ± 1.438.5 ± 1.338.8 ± 1.10.8081138.8 ± 1.338.2 ± 1.439.1 ± 0.90.4500.7090.026
Weight (g) §3286 ± 4243189 ± 4793088 ± 38910.46813226 ± 4483157 ± 4153180 ± 452111
Height (cm) §49.8 ± 2.449.3 ± 2.849.3 ± 1.711149.3 ± 2.949.4 ± 2.249.6 ± 1.6111
Sex (male, n, %) §§18 (60.0)9 (30)16 (53.3)0.0360.7940.11514 (46.7)14 (46.7)15 (50.0)111
Caesarean delivery (n, %) §§6 (20.0)5 (16.7)13 (43.3)10.0940.04711 (36.7)3 (10.0)10 (33.3)0.03010.057
§ Kruskal–Wallis rank sum test with Dunn Kruskal–Wallis multiple comparison of p-values adjusted with the Bonferroni method. §§ Fisher’s exact Test. §§§ Pearson’s Chi-squared test with Yates’ continuity correction. Tertile comparisons: tertile 1 vs. tertile 2 (a), tertile 1 vs. tertile 3 (b), tertile 2 vs. tertile 3 (c). BMI, body mass index; SD, standard deviation.
Table 2. Nutrient differences between mother tertiles in the mothers 8-OHdG group.
Table 2. Nutrient differences between mother tertiles in the mothers 8-OHdG group.
Mothers 8-OHdG Tertiles
Tertile 1 Median (p25, p75)Tertile 2 Median (p25, p75)Tertile 3 Median (p25, p75)p-Value §
abc
Calories (kcal/d)2396 (1712, 3283)1754 (1551, 2345)1645 (1429, 1867)0.2020.0020.399
Carbohydrates (g/d) % kcal/d332.4 (252.2, 478.7)286.4 (249.7, 366.4)266.3 (216.9, 297.0)0.6330.0210.447
56.9 (53.3, 59.7)60.3 (55.9, 63.6)61.0 (54.5, 63.9)0.0530.0861
Lipids (g/d) % kcal/d69.9 (53.9, 102.6)48.6 (43.4, 69.5)45.1 (39.0, 46.9)0.080<0.0010.238
26.1 (24.4, 27.8)24.1 (22.3, 27.4)23.5 (21.6, 26.9)0.2330.0351
Proteins (g/d) % kcal/d102.7 (70.9, 150.6)64.2 (57.6, 94.1)60.5 (55.8, 83.7)0.0530.0020.990
17.0 (15.0, 18.1)15.9 (13.8, 16.9)15.7 (13.7, 18.6)0.0760.9330.666
Vitamin A (ER/d) % adequacy859.1 (545.7, 1224.8)521.6 (428.4, 735.5)489.3 (364.9, 603.7)0.1020.0061
171.8 (109.1, 244.9)104.3 (85.7, 147.1)97.9 (72.9, 120.7)0.1020.0061
Vitamin C (mg/d) % adequacy138.2 (113.4, 222.7)198.3 (147.9, 226.2)157.0 (137.2, 172.8)0.11110.195
230.2 (189.1, 371.2)330.6 (246.6, 377.0)261.6 (228.5, 288.0)0.11110.195
Vitamin E (mg/d) % adequacy4.26 (3.31, 5.13)4.20 (3.51, 4.96)3.69 (3.03, 4.39)10.2960.362
35.4 (27.6, 42.7)35.0 (29.3, 41.3)30.8 (25.3, 36.6)10.2960.362
§ Kruskal–Wallis rank sum test with Dunn Kruskal–Wallis multiple comparison of p-values adjusted with the Bonferroni method. Tertile comparisons: tertile 1 vs. tertile 2 (a), tertile 1 vs. tertile 3 (b), tertile 2 vs. tertile 3 (c). p, percentile.
Table 3. Nutrient differences by mother tertiles in the newborns 8-OHdG group.
Table 3. Nutrient differences by mother tertiles in the newborns 8-OHdG group.
Newborns 8-OHdG Tertile
Tertile 1 Median (p25, p75)Tertile 2 Median (p25, p75)Tertile 3 Median (p25, p75)p-Value §
abc
Calories (kcal/d)2446 (1787, 3283)1772 (1539, 2344)1616 (1334, 1816)0.068<0.0010.284
Carbohydrates (g/d) % kcal/d372.4 (269.0, 478.7)281.9 (245.2, 352.7)256.3 (201.1, 296.2)0.076<0.0010.406
57.4 (54.4, 60.2)59.9 (56.9, 63.6)60.6 (54.4, 62.6)0.4060.6501
Lipids (g/d) % kcal/d73.3 (52.3, 102.8)51.43 (42.24, 69.35)44.85 (41.10, 47.22)0.0912<0.0010.273
25.4 (23.3, 27.3)23.79 (22.28, 27.50)24.28 (22.96, 28.86)0.75411
Proteins (g/d) % kcal/d124.2 (77.2, 157.9)68.3 (58.4, 98.9)61.0 (56.3, 72.7)0.034<0.0010.455
17.1 (14.9, 18.1)15.9 (13.8, 17.7)15.1 (13.8, 17.4)0.3340.2431
Vitamin A (ER/d) % adequacy853.3 (545.1, 1191)590.4 (479.0, 964.4)428.5 (364.9, 539.0)0.499<0.0010.015
170.6 (109.0, 238.2)118.0 (95.8, 192.8)85.7 (72.9, 107.8)0.499<0.0010.015
Vitamin C (mg/d) % adequacy202.3 (124.6, 248.7)161.8 (132.0, 226.2)154.0 (129.6, 172.2)10.1670.576
337.2 (207.7, 414.5)269.8 (220.0, 377.0)256.7 (216.0, 287.0)10.1670.576
Vitamin E (mg/d) % adequacy4.71 (3.65, 5.43)3.87 (3.33, 4.77)3.56 (2.90, 4.32)0.1790.0050.655
39.3 (30.4, 45.2)32.3 (27.7, 39.8)29.6 (24.2, 35.9)0.1790.0050.655
§ Kruskal–Wallis rank sum test with Dunn Kruskal–Wallis multiple comparison of p-values adjusted with the Bonferroni method. Tertile comparisons: tertile 1 vs. tertile 2 (a), tertile 1 vs. tertile 3 (b), tertile 2 vs. tertile 3 (c).
Table 4. Multiple regression analysis for the 8-OHdG levels in mothers and newborns.
Table 4. Multiple regression analysis for the 8-OHdG levels in mothers and newborns.
ParameterMothers 8-OHdG (ng/mL) β (95% CI) ap-ValueNewborns 8-OHdG (ng/mL) β (95% CI) ap-Value
Pregestational BMI
Normal-weightReference Reference
Overweight−0.002 (−0.64 to 0.63)0.9950.048 (−0.56 to 0.66)0.874
Obesity−1.04 (−1.78 to −0.29)0.007−0.977 (−1.69 to −0.26)0.008
Vitamin A (ER/d)
Tertile 1 (91 to 475)Reference Reference
Tertile 2 (485 to 745)−0.123 (−0.90 to 0.66)0.753−1.15 (−1.90 to −0.41)0.003
Tertile 3 (757 to 4028)−1.26 (−2.28 to −0.24)0.016−2.17 (−3.15 to −1.19)<0.001
a Quantile regression model adjusted by caloric intake. CI, confidence interval.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Diaz-Garcia, H.; Vilchis-Gil, J.; Garcia-Roca, P.; Klünder-Klünder, M.; Gomez-Lopez, J.; Granados-Riveron, J.T.; Sanchez-Urbina, R. Dietary and Antioxidant Vitamins Limit the DNA Damage Mediated by Oxidative Stress in the Mother–Newborn Binomial. Life 2022, 12, 1012. https://doi.org/10.3390/life12071012

AMA Style

Diaz-Garcia H, Vilchis-Gil J, Garcia-Roca P, Klünder-Klünder M, Gomez-Lopez J, Granados-Riveron JT, Sanchez-Urbina R. Dietary and Antioxidant Vitamins Limit the DNA Damage Mediated by Oxidative Stress in the Mother–Newborn Binomial. Life. 2022; 12(7):1012. https://doi.org/10.3390/life12071012

Chicago/Turabian Style

Diaz-Garcia, Hector, Jenny Vilchis-Gil, Pilar Garcia-Roca, Miguel Klünder-Klünder, Jacqueline Gomez-Lopez, Javier T. Granados-Riveron, and Rocio Sanchez-Urbina. 2022. "Dietary and Antioxidant Vitamins Limit the DNA Damage Mediated by Oxidative Stress in the Mother–Newborn Binomial" Life 12, no. 7: 1012. https://doi.org/10.3390/life12071012

APA Style

Diaz-Garcia, H., Vilchis-Gil, J., Garcia-Roca, P., Klünder-Klünder, M., Gomez-Lopez, J., Granados-Riveron, J. T., & Sanchez-Urbina, R. (2022). Dietary and Antioxidant Vitamins Limit the DNA Damage Mediated by Oxidative Stress in the Mother–Newborn Binomial. Life, 12(7), 1012. https://doi.org/10.3390/life12071012

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop